NCT04764110View on ClinicalTrials.gov

Short-term Impact of Cyplexinol® on Self-reported Joint Pain

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

January 28, 2022

Study Completion Date

January 28, 2022

Conditions
Joint Pain
Interventions
DIETARY_SUPPLEMENT

Cyplexinol

partially hydrolyzed Collagen and its associated proteins including Bone Morphogenetic Proteins (BMPs)

OTHER

Placebo

Maltodextrin

Trial Locations (1)

38152

Center for Nutraceutical and Dietary Supplement Reseach, Memphis

All Listed Sponsors
collaborator

ZyCal Bioceuticals

UNKNOWN

lead

University of Memphis

OTHER

NCT04764110 - Short-term Impact of Cyplexinol® on Self-reported Joint Pain | Biotech Hunter | Biotech Hunter